These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15910291)

  • 1. The effect of different immunosuppressive regimens on TGF-beta1 expression in kidney transplant patients.
    Matl I; Viklický O; Voska L; Lodererová A; Vítko S
    Transpl Int; 2005 Jun; 18(6):668-71. PubMed ID: 15910291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta1 expression and chronic allograft nephropathy in protocol kidney graft biopsy.
    Viklický O; Matl I; Voska L; Böhmová R; Jaresová M; Lácha J; Lodererová A; Stríz I; Teplan V; Vítko S
    Physiol Res; 2003; 52(3):353-60. PubMed ID: 12790768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of transforming growth factor-beta1 in renal transplant recipients receiving different immunosuppressive regimens.
    Citterio F; Pozzetto U; Romagnoli J; Tondolo E; Silvestri P; Nanni G; Castagneto M
    Transplant Proc; 2004 Apr; 36(3):698-9. PubMed ID: 15110635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gingival crevicular fluid transforming growth factor-beta1 in cyclosporine and tacrolimus treated renal transplant patients without gingival overgrowth.
    Gürkan A; Afacan B; Emingil G; Töz H; Başkesen A; Atilla G
    Arch Oral Biol; 2008 Aug; 53(8):723-8. PubMed ID: 18342291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
    Filler G; Webb NJ; Milford DV; Watson AR; Gellermann J; Tyden G; Grenda R; Vondrak K; Hughes D; Offner G; Griebel M; Brekke IB; McGraw M; Balzar E; Friman S; Trompeter R
    Pediatr Transplant; 2005 Aug; 9(4):498-503. PubMed ID: 16048603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial.
    Meier M; Nitschke M; Weidtmann B; Jabs WJ; Wong W; Suefke S; Steinhoff J; Fricke L
    Transplantation; 2006 Apr; 81(7):1035-40. PubMed ID: 16612281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta1, vascular endothelial growth factor, and bone morphogenic protein-7 expression in tacrolimus-induced nephrotoxicity in rats.
    Oğütmen B; Tuğlular S; Cakalağaoğlu F; Ozener C; Akoğlu E
    Transplant Proc; 2006 Mar; 38(2):487-9. PubMed ID: 16549155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [TGF-beta1 in allograft and long-term renal function].
    Wang PX; Huang XY; Wang AJ; Huang CB; Fan MQ; Zhang YP
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):700-3. PubMed ID: 16114562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
    Morales JM; Andrés A; Dominguez-Gil B; Arriola M; Gutiérrez MJ; Hernández E; Ortuño T; Praga M
    Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta1 gene expression and cyclosporine A-induced gingival overgrowth: a pilot study.
    Radwan-Oczko M; Boratyńska M; Zietek M; Dobosz T
    J Clin Periodontol; 2008 May; 35(5):371-8. PubMed ID: 18355347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and structural consequences of early renal allograft injury.
    Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
    Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients].
    Iñigo P; Lario S; Campistol JM; Bescós M; Campos B; Oppenheimer F
    Nefrologia; 2003; 23(4):312-20. PubMed ID: 14558330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of tacrolimus and cyclosporin in renal transplantation by the protocol biopsies.
    Töz H; Sen S; Seziş M; Duman S; Ozkahya M; Ozbek S; Hoşcoşkun C; Atabay G; Ok E
    Transplant Proc; 2004; 36(1):134-6. PubMed ID: 15013324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of cyclosporin and tacrolimus on the expression of fibrosis-associated genes in isolated glomeruli from renal transplants.
    Bicknell GR; Williams ST; Shaw JA; Pringle JH; Furness PN; Nicholson ML
    Br J Surg; 2000 Nov; 87(11):1569-75. PubMed ID: 11091247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and clinical response to angiotensin II receptor antagonist in kidney transplant patients with chronic allograft nephropathy.
    Mas VR; Alvarellos T; Maluf DG; Ferreira-Gonzalez A; Oliveros L; Maldonado RA; de Boccardo G
    Transpl Int; 2004 Oct; 17(9):540-4. PubMed ID: 15349718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation.
    Yu X; Zhang B; Xing C; Sun B; Liu M; Zhang W; Gu M
    Transplant Proc; 2008 Dec; 40(10):3455-9. PubMed ID: 19100412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.